Since we observed antitumorigenic effects after L1CAM knockdown in RB cells and additionally demonstrated that L1CAM expression seems to be decreased in patients after chemotherapeutic treatment, we hypothesized an effect of L1CAM depletion on chemotherapy‐resistant RB cells. The gene discussed is L1CAM; the disease is retinoblastoma.